Revance The — Company Overview, News & Financial Data

Revance (NASDAQ:RVNC) is a biotechnology firm focused on the development, manufacturing, and commercialization of innovative neuromodulators and therapeutics for treating a variety of aesthetic and therapeutic conditions. The company is known for its dedication to advancing the science of movement and expression through research in the neuromodulator space. Revance's portfolio includes treatments aimed at conditions such as cervical dystonia and aesthetic enhancements. A keystone project is the development of a next-generation neuromodulator product, designed to offer longer-lasting results in the treatment of dynamic facial lines and medical conditions characterized by muscle spasticity. Revance's objective is to revolutionize the neuromodulator sector by providing superior solutions that improve patient outcomes and enhance quality of life.